Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Aug 16, 2023 · 10-Q · 47 days after period end · 0001740797-23-000066
| Metric | Q1 2024 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$411.52K | $396.33K | $48.68K | -$14.70K |
| EPS Diluted | — | — | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 16, 2023 · 47 d after period end
